Last $89.84 USD
Change Today +0.11 / 0.12%
Volume 952.0K
NVS On Other Exchanges
Symbol
Exchange
SIX Swiss Ex
Xetra
New York
OTC US
Mexico
Frankfurt
SIX Swiss Ex
As of 8:04 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

Lichtstrasse 35

Basel, 4056

Switzerland

Phone: 41 61 324 11 11

Fax:

This division offers a range of products to treat various eye diseases and conditions, and is organized into three businesses, including Surgical, Ophthalmic Pharmaceuticals, and Vision Care. This division sells products in 180 markets and runs operations in 75 countries. This division works together with the Novartis Institutes for BioMedical Research, the company’s global pharmaceutical research organization. Surgical The company’s Alcon division's Surgical business offers ophthalmic surgical equipment, instruments, disposable products, and intraocular lenses (IOLs) for surgical procedures that address cataracts, vitreoretinal conditions, glaucoma, and refractive errors. Alcon's Surgical portfolio includes the Infiniti vision system to perform cataract surgeries, the Constellation vision system for retinal operations, and the Wavelight refractive suite for refractive procedures. Alcon also offers the AcrySof family of IOLs to treat cataracts, including the AcrySof IQ, AcrySof IQ ReSTOR, AcrySof IQ Toric, and AcrySof IQ ReSTOR Toric IOLs, as well as the LenSx femtosecond laser, a cataract surgery technology that increases precision and reproducibility for the corneal incision, capsulorhexis, and lens fragmentation steps of the procedure. In addition, Alcon provides advanced viscoelastics, surgical solutions, surgical packs, and other disposable products for cataract and vitreoretinal surgery. Ophthalmic Pharmaceuticals The company’s Alcon division's Ophthalmic Pharmaceuticals business combines Alcon's range of pharmaceuticals with selected ophthalmic products (excluding Lucentis). The products treat chronic and acute conditions of the eye, including glaucoma, elevated intraocular pressure (associated with glaucoma), eye infection and inflammation, eye allergies, and dry eye. Its Alcon division's Ophthalmic Pharmaceuticals business also oversees the line of professionally driven OTC brands that include artificial tears and ocular vitamins. Product highlights within its Alcon division's Ophthalmic Pharmaceuticals portfolio include Travatan Z ophthalmic solution and DuoTrav ophthalmic solution for the treatment of elevated intraocular pressure associated with glaucoma; Vigamox ophthalmic solution for bacterial conjunctivitis; Pataday ophthalmic solution for ocular itching associated with allergic conjunctivitis; Nevanac ophthalmic suspension for eye inflammation following cataract surgery; and the Systane family of OTC products for dry eye relief. Vision Care The company’s Alcon division's Vision Care business combines the portfolio of contact lenses and lens care products with Alcon's contact lens care solution portfolio. This includes the Opti-Free line of multi-purpose disinfecting solutions, as well as the Clear Care and AOSept Plus hydrogen peroxide lens care solutions. Alcon also offers a portfolio of silicone hydrogel, daily disposables, and color contact lenses, including its Air Optix, Dailies, and Freshlook brands, as well as its innovation of Dailies Total1. Through the integration of CIBA Vision products, Alcon is the major manufacturer across contact lenses and lens care products. New Products AcrySof IQ ReSTOR Multifocal Toric IOL—advanced technology intraocular lenses to correct cataracts, as well as refractive errors like astigmatism for improved near and intermediate vision, launched in China. Cataract Refractive Suite—suite of tools for use during cataract surgery launched in the U.S. and EU. Centurion vision system—Alcon's next-generation phacoemulsification system for use during cataract surgery launched in the U.S. and EU. Air Optix Colors lenses—silicone hydrogel, color cosmetic contact lenses received EMA (the European Medicines Agency) approval for natural eye color enhancement. Dailies Aqua Comfort Plus Toric lenses—silicone hydrogel, daily disposable contact lenses for improving refractive errors, such as astigmatism, received FDA approval. Dailies Illuminate lenses—color contact lenses introduced a new color, Light Brown, in Japan. Dailies Total1 lenses—daily disposable, water gradient contact lenses launched in the U.S., Switzerland, Canada, UK, Spa

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NVS:US $89.84 USD +0.11

NVS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Johnson & Johnson $103.73 USD +0.78
Merck & Co Inc $60.11 USD +0.11
Pfizer Inc $29.39 USD +0.01
Roche Holding AG SFr.267.70 CHF +0.60
Procter & Gamble Co/The $83.11 USD +0.08
View Industry Companies
 

Industry Analysis

NVS

Industry Average

Valuation NVS Industry Range
Price/Earnings 24.1x
Price/Sales 3.7x
Price/Book 3.1x
Price/Cash Flow 24.8x
TEV/Sales 3.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NOVARTIS AG-ADR, please visit www.novartis.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.